Table 1 Baseline characteristics of the patients included in the study
Overall | HF | HF & CA | CA | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2983 | 371 | 691 | 1921 | p-value | |||||||||||||
PC- | PC+ | PC- | PC+ | PC- | PC+ | PC- | PC+ | ||||||||||
2249 | 75% | 734 | 25% | 355 | 96% | 16 | 4% | 584 | 85% | 107 | 15% | 1310 | 68% | 611 | 32% | < 0.001 | |
Sex | 0.006 | ||||||||||||||||
Women | 876 | 39% | 266 | 36% | 153 | 43% | 4 | 25% | 199 | 34% | 29 | 27% | 524 | 40% | 233 | 38% | |
Men | 1373 | 61% | 468 | 64% | 202 | 57% | 12 | 75% | 385 | 66% | 78 | 73% | 786 | 60% | 378 | 62% | |
Age | 75 | 66–84 | 68 | 58–75 | 82 | 74–89 | 77 | 73–86 | 77 | 69–84 | 74 | 69–79 | 73 | 64–81 | 67 | 56–75 | < 0.001 |
Comorbidities | |||||||||||||||||
COPD | 179 | 8% | 38 | 5% | 41 | 12% | 2 | 13% | 70 | 12% | 8 | 7% | 68 | 5% | 28 | 5% | < 0.001 |
Dementia | 182 | 8% | 21 | 3% | 50 | 14% | 3 | 19% | 55 | 9% | 6 | 6% | 77 | 6% | 12 | 2% | < 0.001 |
CKD | 714 | 32% | 184 | 25% | 133 | 37% | 11 | 69% | 289 | 49% | 58 | 54% | 292 | 22% | 115 | 19% | < 0.001 |
LOS (in days) | 6 | 3–13 | 12 | 7–21 | 3 | 2–7 | 11 | 8–17 | 9 | 5–16 | 13 | 8–20 | 6 | 3–13 | 11 | 7–21 | < 0.001 |
LOS before PC | 3 | 0–8 | 6 | 4–9 | 6 | 2–13 | 3 | 0–13 | < 0.001 | ||||||||
LOS after PC | 7 | 3–13 | 4 | 3–7 | 5 | 3–9 | 7 | 3–14 | < 0.001 | ||||||||